Projects per year
Personal profile
Expertise
- Postdoctoral Researcher VLAIO Innovation mandate (2023 - Present)
- PhD in Pharmaceutical Sciences (2016 - 2023)
- FWO PhD fellowship (2016 - 2020)
- Master of Science in Drug Development - Pharmacist (2011-2016)
Fingerprint
Dive into the research topics where Jessie Neuckermans is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
VLAIM5: Innovation mandate Spin-off: EVOZymes Development Platform
Neuckermans, J. (Mandate), De Kock, J. (Administrative Promotor) & Vanhaecke, T. (CoI (Co-Promotor))
1/08/23 → 31/07/25
Project: Applied
-
FWOTM809: Preclinical development of a novel gene-based therapy for hereditary tyrosinemia type 1
Neuckermans, J. (Mandate) & De Kock, J. (Administrative Promotor)
1/10/16 → 30/09/20
Project: Fundamental
-
4-HYDROXYPHENYLPYRUVATE DIOXYGENASE VARIANTS
De Kock, J. (Inventor), Neuckermans, J. (Inventor), Vanhaecke, T. (Inventor), Schwaneberg, U. (Inventor) & DHOKE, G. (Inventor), 2026, Patent No. EP4720266Research output: Patent
-
Engineering the gut as an auxiliary tyrosine disposal unit in hereditary tyrosinemia type 1
De Kock, J., Paganelli, M. & Neuckermans, J., 5 Aug 2026, In: Molecular Therapy. 34, 8, p. 4367-4369 3 p.Research output: Contribution to journal › Comment/debate
-
Liver-directed AAV gene therapy metabolically corrects AKU in Hgd deficient mice
Lequeue, S., Norman, B. P., Del’haye, G. G., Neuckermans, J., Colemonts-Vroninks, H., Hughes, J. H., Rombaut, M., Claes, P., Heymans, A., Heremans, Y., Leuckx, G., Mortier, A., Ranganath, L., Gallagher, J. A., Vanhaecke, T., Bou-Gharios, G. & Kock, J. D., 2 Jun 2026Research output: Other contribution
-
A robust bacterial high-throughput screening assay to identify pharmacological chaperones targeting human homogentisate 1,2-dioxygenase missense variants in alkaptonuria
Lequeue, S., Allach, H., Nulmans, I., Desmet, L., Salvi, N. S., Rombaut, M., Neuckermans, J., Schwaneberg, U., Vanhaecke, T. & Kock, J. D., Oct 2025, In: European Journal of Pharmacology. 1005, 13 p., 178048.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)1 Downloads (Pure) -
Current state of the treatment landscape of phenylketonuria
Nulmans, I., Lequeue, S., Desmet, L., Neuckermans, J. & De Kock, J., 5 Jun 2025, In: Orphanet Journal of Rare Diseases. 20, 1, p. 281 16 p., 281.Research output: Contribution to journal › Article › peer-review
Open AccessFile18 Citations (Scopus)2 Downloads (Pure)
Datasets
-
Gene expression profiling of Fah- and Hgd-deficient mouse livers upon short-term nitisinone discontinuation
Neuckermans, J. (Creator), Claes, P. (Researcher), Heymans, A. (Researcher), Colemonts-Vroninks, H. (Project Member), Martens, G. (Project Member), Vanhaecke, T. (Supervisor) & De Kock, J. (Supervisor), NCBI Gene Expression Omnibus, 4 Apr 2023
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE225001
Dataset
Prizes
-
FWO PhD fellowship fundamental research
Neuckermans, J. (Recipient), 1 Oct 2016
Prize: Fellowship awarded competitively
Activities
-
The Research Track Gentrepreneur
Neuckermans, J. (Participant)
16 Jan 2025 → 30 Jan 2025Activity: Participating in or organising an event › Participation in workshop, seminar
-
Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen Annual Conference and Seminar of the Society for Inborn Errors of Metabolism 2025
Neuckermans, J. (Participant)
4 Mar 2025 → 7 Mar 2025Activity: Participating in or organising an event › Participation in conference
-
Annual Conference of the Society for Inborn Errors of Metabolism.
Neuckermans, J. (Speaker)
4 Mar 2025 → 7 Mar 2025Activity: Talk or presentation › Talk or presentation at a conference
-
Supervision Training for PostDocs
Neuckermans, J. (Participant)
26 Nov 2024Activity: Participating in or organising an event › Participation in workshop, seminar
-
SSIEM 2024 Annual Symposium: Exploring New Horizons
Neuckermans, J. (Participant)
3 Sept 2024 → 6 Sept 2024Activity: Participating in or organising an event › Participation in conference
Thesis
-
Bepaling van het optimale mRNA elektroporatieprotocol voor humane huidafgeleide stamcellen.
Neuckermans, J. ((PhD) Student) & Vanhaecke, T. (Promotor), 2016Student thesis: Master's Thesis
-
Casting error prone PCR mutagenesis of 4-hydroxyphenylpyruvate dioxygenase to decrease its sensitivity towards nitisinone
Neuckermans, J. (Co-promotor), De Kock, J. (Promotor) & Cassar, J. ((PhD) Student), 2019Student thesis: Master's Thesis
-
Characterization of the cellular damage in the FRG mouse model of hereditary tyrosinemia type 1 after withdrawal of the orphan drug NTBC
Neuckermans, J. (Co-promotor), De Kock, J. (Promotor) & Nysten, L. ((PhD) Student), 2017Student thesis: Master's Thesis
-
Development of a human cell-based in vitro assay aiming the functionality assessment of an NTBC-tolerant variant of HPD
Neuckermans, J. (Co-promotor), De Kock, J. (Promotor) & El Kadi, M. ((PhD) Student), 2021Student thesis: Master's Thesis
-
Establishment of the optimal mRNA electroporation protocol for human skin-derived stem cells
Neuckermans, J. ((PhD) Student) & De Kock, J. (Promotor), De Kock, J. (Promotor), 2016Student thesis: Master's Thesis